Heparin against inflammation: Targeting evolution and clinical impacts

Area of Science:

• Pharmacology
• Biochemistry
• Immunology

Background:

• Heparin's complex polysaccharide structure enables interactions with diverse bioactive molecules, leading to effects beyond anticoagulation.
• Thrombo-inflammation involves complex interactions, presenting opportunities for novel therapeutic strategies.
• Heparin's anti-inflammatory properties are increasingly recognized, suggesting expanded clinical applications.

Purpose of the Study:

• To provide a comprehensive clinical profile of inflammatory disorders benefiting from heparin.
• To explore heparin's multifaceted pharmacological effects in managing thrombo-inflammation.
• To bridge the gap between heparin's biological mechanisms and its clinical use in inflammatory conditions.

Main Methods:

• Systematic review of clinical data and scientific literature on heparin's role in inflammatory disorders.
• Analysis of heparin's multi-targeting mechanisms against thrombo-inflammation.
• Compilation of evidence for heparin administration in conditions such as sepsis, pregnancy, pulmonary disease, pancreatitis, nephropathy, and skin disorders.

Main Results:

• Heparin demonstrates significant therapeutic potential in managing a range of inflammatory conditions.
• Multiple targeting mechanisms contribute to heparin's anti-inflammatory and anti-thrombo-inflammatory effects.
• Clinical applications of heparin in inflammatory indications are expanding, though often based on empirical evidence.

Conclusions:

• Heparin possesses multifaceted pharmacological effects applicable to various inflammatory disorders.
• Further research is warranted to fully elucidate heparin's mechanisms and optimize its use in treating inflammation.
• Heparin represents a promising therapeutic agent for managing thrombo-inflammation and related inflammatory conditions.